Theseus Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	20.52	23.95	33.61	30.18	38.74	41.16
Investment Securities	118.34	66.94	73.4	69.13	80.7	26.07
Trading Asset Securities	-	0.09	0.31	0.48	0.05	-
Mortgage-Backed Securities	-	55.83	64.13	68.03	68.86	-
Total Investments	118.34	122.86	137.85	137.64	149.61	26.07
Gross Loans	387.93	373.67	334.14	273.05	179.59	152.38
Allowance for Loan Losses	-3.56	-4.09	-3.73	-3.42	-2.1	-0.91
Other Adjustments to Gross Loans	-	-	-	-	-0.33	-1.13
Net Loans	384.37	369.59	330.41	269.63	177.16	150.35
Property, Plant & Equipment	-	1.32	1.64	1.42	1.75	2.1
Accrued Interest Receivable	-	1.84	1.76	1.45	1.08	0.85
Other Long-Term Assets	8.1	5.61	5.88	4.8	4.64	0.58
Total Assets	531.33	525.16	511.15	445.11	372.98	221.1
Interest Bearing Deposits	368.69	340.81	353.06	213.28	202.14	118.02
Institutional Deposits	-	22.03	8	2.76	2.22	3.3
Non-Interest Bearing Deposits	104.23	92.61	99.39	176.82	100.96	27.41
Total Deposits	472.92	455.45	460.45	392.86	305.32	148.73
Short-Term Borrowings	-	15.09	0.31	0.48	0.05	-
Current Portion of Long-Term Debt	-	-	-	10	-	-
Current Portion of Leases	-	0.34	-	-	-	-
Accrued Interest Payable	-	0.47	0.4	0.09	0.02	0.03
Long-Term Debt	9	-	-	-	8.03	24.95
Federal Home Loan Bank Debt, Long-Term	-	9	9	-	-	-
Long-Term Leases	-	0.81	1.44	1.15	1.4	1.63
Other Long-Term Liabilities	3.26	1.78	1.95	2.09	1.18	0.91
Total Liabilities	485.18	482.94	473.55	406.67	316.01	176.25
Common Stock	73.29	73.17	66.69	65.82	65.11	49.73
Retained Earnings	-15.66	-16.08	-11.78	-7.33	-6.97	-5.4
Comprehensive Income & Other	-11.48	-14.87	-17.31	-20.05	-1.17	0.53
Shareholders' Equity	46.15	42.22	37.6	38.44	56.98	44.86
Total Liabilities & Equity	531.33	525.16	511.15	445.11	372.98	221.1
Total Debt	9	25.24	10.75	11.63	9.48	26.58
Net Cash (Debt)	11.52	-1.2	23.17	19.03	29.31	14.59
Net Cash Growth	-46.40%	-	21.78%	-35.08%	100.96%	-
Net Cash Per Share	1.44	-0.16	3.48	2.88	5.12	2.87
Filing Date Shares Outstanding	8.05	7.99	6.7	6.6	6.6	5.1
Total Common Shares Outstanding	8.05	7.99	6.7	6.6	6.6	5.1
Book Value Per Share	5.73	5.28	5.62	5.82	8.63	8.79
Tangible Book Value	46.15	42.22	37.6	38.44	56.98	44.86
Tangible Book Value Per Share	5.73	5.28	5.62	5.82	8.63	8.79

Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Banks template. Financial Sources.